F-Prime Capital Partners vs GV (Google Ventures)
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| F-Prime Capital Partners | GV (Google Ventures) | |
|---|---|---|
| Type | Venture capital | Corporate VC |
| HQ | Cambridge | Mountain View |
| Founded | 2002 | 2009 |
| Check size | $3M – $10M | $250K – $50M |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS | AI & Machine Learning, Biotech, Cloud Computing, Cybersecurity, Data & Infrastructure, Deep Tech, Developer Tools, Digital Health, Enterprise Software, Fintech, Hardware, Healthtech, Longevity, Medical Devices, Mental Health, Robotics, SaaS, Sector Agnostic, Semiconductors |
| AUM | $13B | $13B |
| Tracked investments | 378 | 299 |
| Exits (acquired/public) | 6 | 11 |
| Led rounds on record | — | 9 |
| Dated deals, last 24 mo | 5 | 8 |
Shared portfolio · 15
Aera TherapeuticsAffinia TherapeuticsBeam TherapeuticsComanche BiopharmaDevoted HealthInvetxIora HealthLeyden LabsMetseraNeo4jOWKINPrime MedicineRhyGaze AGVerve TherapeuticsCurie Bio
Frequently asked questions
- Do F-Prime Capital Partners and GV (Google Ventures) invest together?
- Yes — F-Prime Capital Partners and GV (Google Ventures) appear together in 15 tracked portfolio companies, including Aera Therapeutics, Affinia Therapeutics, Beam Therapeutics, Comanche Biopharma, Devoted Health.
- How do F-Prime Capital Partners and GV (Google Ventures) compare on check size?
- F-Prime Capital Partners typically writes checks of $3M – $10M, while GV (Google Ventures) writes $250K – $50M.